ArticleNPJ vaccines2026

Long-term cross-variant Fc-mediated immune responses against SARS-CoV-2 induced by a heterologous adenoviral/inactivated virus prime-boost vaccination strategy.

Doyoung Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.